• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Gilead Sciences

Gilead Sciences

Gilead Sciences Inc GILD 4 Star

Last Price$107.78Day Change (%)-0.19%
Open Price$106.96Day Change ($)-0.21
Day Range106.78–108.7952-Week Range85.95–123.37

As of Fri 8/28/2015 5:14:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. UPDATE: Apple, Amazon and Google top lists of 'buy ideas' after selloff

    UPDATE: Apple, Amazon and Google top lists of 'buy ideas' after selloff

  2. Research and Markets: Analyzing the Global Biotechnology Industry 2015 - The Medical/Healthcare Segment is the Leading Segment of the Biotechnology Industry Consisting of Nearly 60%

    Research and Markets: Analyzing the Global Biotechnology Industry 2015 - The Medical/Healthcare Segment is the Leading Segment of the Biotechnology Industry Consisting of Nearly 60%

  3. Research and Markets: Ventricular Tachycardia Global Clinical Trials Review, H1 2015 - Clinical Trial Overview of Top Companies

    Research and Markets: Ventricular Tachycardia Global Clinical Trials Review, H1 2015 - Clinical Trial Overview of Top Companies

  4. 10 S&P 500 companies with the fastest sales growth

    10 S&P 500 companies with the fastest sales growth

  5. UPDATE: 10 S&P 500 companies with the fastest sales growth

    UPDATE: 10 S&P 500 companies with the fastest sales growth

  6. UPDATE: 10 S&P 500 companies with the fastest sales growth

    UPDATE: 10 S&P 500 companies with the fastest sales growth

  7. UPDATE: Facebook, Whole Foods slip after earnings reports

    UPDATE: Facebook, Whole Foods slip after earnings reports

  8. UPDATE: U.S. stocks end higher as Fed leaves September hike on the table

    UPDATE: U.S. stocks end higher as Fed leaves September hike on the table

  9. Gilead Sciences Carving Out a Wider Moat

    StockInvestor editor Matt Coffina and senior biotech analyst Karen Andersen discuss Gilead's growing competitive advantages.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.